Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
26 studies found for:    " May 02, 2012":" June 01, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Active, not recruiting Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®
Conditions: Diabetic Retinopathy;   HIV
Interventions: Drug: Tesamorelin;   Drug: Placebo-Control
22 Withdrawn Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone
Condition: HIV
Interventions: Drug: Atazanavir;   Drug: Darunavir;   Drug: Ritonavir;   Drug: Optimized NRTI backbone
23 Unknown  Nucleoside Switch Pilot for Virologically Controlled HIV Subjects With Decreasing CD4 Cells Who Have Received TDF-based ARV Therapy
Condition: HiV1- Positive
Intervention: Drug: Abacavir/Lamivudine
24 Completed Study to Optimize the Quality of Samples for Cell-mediated Immunity (CMI) in ART-naïve HIV-1-infected Subjects
Condition: AIDS
Intervention: Procedure: Blood sample collection
25 Completed Estimate the Effect of Telaprevir and Boceprevir on Maraviroc Pharmacokinetics in Healthy Subjects
Condition: Healthy
Interventions: Drug: Maraviroc;   Drug: Maraviroc + Boceprevir;   Drug: Maraviroc + Telaprevir
26 Recruiting Pre-exposure Prophylaxis Adherence Intervention for MSM
Condition: Medication Adherence
Interventions: Behavioral: CBT-based counseling;   Behavioral: Health education and supportive counseling

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-26) Next Page   
Indicates status has not been verified in more than two years